Resultados da pesquisa - brain ((((((tumor re) OR (tumor 1))s) or (tumor rates))) or (((tumor re) OR (tumor 1)))) treat

Pesquisas alternativas:
tumor rates » tumour rates (Expandir a Pesquisa), tumor rate (Expandir a Pesquisa), tumor states (Expandir a Pesquisa)
tumor re » tumor role (Expandir a Pesquisa), tumor rna (Expandir a Pesquisa)
tumor 1 » tumor _ (Expandir a Pesquisa), tumor a (Expandir a Pesquisa)

1

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

Por Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves
Publicado em 2012

“... 15-3), CYFRA 21-1), and of serum non-tumor markers (lactate deshydrogenase (LDH), alkaline...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

Por Curtin, James F, Liu, Naiyou, Candolfi, Marianela, Xiong, Weidong, Assi, Hikmat, Yagiz, Kader, Edwards, Matthew R, Michelsen, Kathrin S, Kroeger, Kurt M, Liu, Chunyan, Muhammad, A. K. M. Ghulam, Clark, Mary C, Arditi, Moshe, Comin-Anduix, Begonya, Ribas, Antoni, Lowenstein, Pedro R, Castro, Maria G
Publicado em 2009

“.... Increased levels of HMGB1 were also detected in the serum of tumor-bearing Ad-Flt3L/Ad-TK (+GCV)-treated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

PC1/3 KD Macrophages Exhibit Resistance to the Inhibitory Effect of IL-10 and a Higher TLR4 Activation Rate, Leading to an Anti-Tumoral Phenotype

PC1/3 KD Macrophages Exhibit Resistance to the Inhibitory Effect of IL-10 and a Higher TLR4 Activation Rate, Leading to an Anti-Tumoral Phenotype

Por Franck Rodet, Alice Capuz, Bilgehan-Aybike Ozcan, Rémy Le Beillan, Antonella Raffo-Romero, Firas Kobeissy, Marie Duhamel, Michel Salzet
Publicado em 2019-11-01

Assuntos: “...anti-tumoral immunotherapy...”
Obter o texto integral

Artigo

4

RBTT-05. TUMOR TREATING FIELDS AND RADIOSURGERY FOR SUPRA- AND/OR INFRATENTORIAL BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS STUDY

RBTT-05. TUMOR TREATING FIELDS AND RADIOSURGERY FOR SUPRA- AND/OR INFRATENTORIAL BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS STUDY

Por P Mehta, Minesh, Gondi, Vinai, Ahluwalia, Manmeet, D Brown, Paul
Publicado no Neuro Oncol (2018)

“...BACKGROUND: Tumor Treating Fields (TTFields) are non-invasive, loco-regional, anti-mitotic...”
Obter o texto integral
Obter o texto integral

Artigo

5

P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study

P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study

Por Bähr, O, Mehta, M, Gondi, V, Ahluwalia, M, Brown, P
Publicado no Neuro Oncol (2018)

“...BACKGROUND: Tumor Treating Fields (TTFields) are non-invasive, loco-regional, anti-mitotic...”
Obter o texto integral
Obter o texto integral

Artigo

6

TRTH-10. PEDIATRIC PHASE 1/1B STUDY OF ENTRECTINIB IN PATIENTS WITH PRIMARY BRAIN TUMORS, NEUROBLASTOMA, AND NTRK, ROS1, OR ALK FUSIONS

TRTH-10. PEDIATRIC PHASE 1/1B STUDY OF ENTRECTINIB IN PATIENTS WITH PRIMARY BRAIN TUMORS, NEUROBLASTOMA, AND NTRK, ROS1, OR ALK FUSIONS

Por Rangaraju, Sunitha, Li, Gang, Christiansen, Jason, Hornby, Zachary, Multani, Pratik, Esquibel, Vanessa, Maneval, Edna Chow
Publicado no Neuro Oncol (2017)

“... brain tumors, neuroblastoma, and other non-neuroblastoma, extracranial solid tumors harboring NTRK, ROS1...”
Obter o texto integral
Obter o texto integral

Artigo

7

PATH-55. THE POTENTIAL ROLE OF ERCC1 AS A BIOMARKER FOR PLATINUM BASED THERAPY IN PRIMARY AND METASTATIC BRAIN TUMORS

PATH-55. THE POTENTIAL ROLE OF ERCC1 AS A BIOMARKER FOR PLATINUM BASED THERAPY IN PRIMARY AND METASTATIC BRAIN TUMORS

Por Kim, Lyndon, Judy, Kevin, Farrell, Christopher, Evans, James, Andrews, David
Publicado no Neuro Oncol (2017)

“... brain tumors is not known. We reviewed a total of 163 patients who had ERCC1 test based on molecular...”
Obter o texto integral
Obter o texto integral

Artigo

8

IMMU-37. VEMURAFENIB ENHANCES THE CYTOTOXICITY OF NY-ESO-1 TCR ENGINEERED T-CELLS FOR BRAF MUTANT BRAIN TUMORS

IMMU-37. VEMURAFENIB ENHANCES THE CYTOTOXICITY OF NY-ESO-1 TCR ENGINEERED T-CELLS FOR BRAF MUTANT BRAIN TUMORS

Por Bethel, Jacob, Aliche, Julian, Orpilla, Joey, Soto, Horacio, Everson, Richard, Davidson, Tom, Wang, Anthony, Liau, Linda, Prins, Robert
Publicado no Neuro Oncol (2018)

“..., and maximal oxygen consumption rate (OCR), whereas T-cells co-cultured with vemurafenib treated tumor cells...”
Obter o texto integral
Obter o texto integral

Artigo

9

Flt3L in Combination With HSV1-TK-mediated Gene Therapy Reverses Brain Tumor–induced Behavioral Deficits

Flt3L in Combination With HSV1-TK-mediated Gene Therapy Reverses Brain Tumor–induced Behavioral Deficits

Por King, Gwendalyn D, Kroeger, Kurt M, Bresee, Catherine J, Candolfi, Marianela, Liu, Chunyan, Manalo, Charlene M, Muhammad, AKM Ghulam, Pechnick, Robert N, Lowenstein, Pedro R, Castro, Maria G
Publicado em 2008

“...Glioblastoma multiforme (GBM) is an invasive and aggressive primary brain tumor which is associated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

P14.19 Preclinical and clinical efficacy of entrectinib in primary and metastatic brain tumors harboring NTRK, ROS1, or ALK gene fusions

P14.19 Preclinical and clinical efficacy of entrectinib in primary and metastatic brain tumors harboring NTRK, ROS1, or ALK gene fusions

Por Rangaraju, S., Farago, A., Heym, K. M., Ahn, M., Drilon, A., Potts, S., Hornby, Z., Multani, P., Li, G.
Publicado no Neuro Oncol (2017)

“... brain tumors represent a critical unmet medical need in neuro-oncology. NTRK, ROS1, and ALK gene fusions...”
Obter o texto integral
Obter o texto integral

Artigo

11

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

Por Lee, Eudocia Q., Kuhn, John, Lamborn, Kathleen R., Abrey, Lauren, DeAngelis, Lisa M., Lieberman, Frank, Robins, H. Ian, Chang, Susan M., Yung, W. K. Alfred, Drappatz, Jan, Mehta, Minesh P., Levin, Victor A., Aldape, Kenneth, Dancey, Janet E., Wright, John J., Prados, Michael D., Cloughesy, Timothy F., Gilbert, Mark R., Wen, Patrick Y.
Publicado em 2012

“.... The North American Brain Tumor Consortium examined the safety, pharmacokinetics, and efficacy of combination...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

$Hypofractionated Stereotactic Radiotherapy for Primary and Secondary Intrapulmonary Tumors: First Results of a Phase I/II Study$

Hypofractionated Stereotactic Radiotherapy for Primary and Secondary Intrapulmonary Tumors: First Results of a Phase I/II Study

Por Ernst-Stecken, Antje, Lambrecht, Ulrike, Mueller, Reinhold, Sauer, Rolf, Grabenbauer, Gerhard
Publicado em 2006

“... in hypofractionated stereotactic radiotherapy (hfSRT) for intrapulmonary tumors with the Novalis™ system (BrainLAB AG...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

MNGI-41. LARGE VOLUME RE-IRRADIATION FOR RECURRENT MENINGIOMA WITH PULSED REDUCED DOSE RATE RADIOTHERAPY

MNGI-41. LARGE VOLUME RE-IRRADIATION FOR RECURRENT MENINGIOMA WITH PULSED REDUCED DOSE RATE RADIOTHERAPY

Por Witt, Jacob, Musunuru, Hima, Bayliss, Adam, Howard, Steven
Publicado no Neuro Oncol (2018)

“.... All patients were re-treated with IMRT at an apparent dose rate of 0.0667 Gy/min. Median time between...”
Obter o texto integral
Obter o texto integral

Artigo

14

Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors

Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors

Por Waters, Alicia M., Johnston, James M., Reddy, Alyssa T., Fiveash, John, Madan-Swain, Avi, Kachurak, Kara, Bag, Asim K., Gillespie, G. Yancey, Markert, James M., Friedman, Gregory K.
Publicado no Hum Gene Ther Clin Dev (2017)

“... efficacy in the treatment of malignant brain tumors. G207 is a genetically engineered HSV-1 lacking genes...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

PT-04 PRELIMINARY RESULTS OF A PHASE I/II STUDY OF INTRA-ARTERIAL CHEMOTHERAPY WITH OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION FOR PATIENTS WITH RECURRENT OR PROGRESSIVE CNS EMBRYONAL OR GERM CELL TUMORS

PT-04 PRELIMINARY RESULTS OF A PHASE I/II STUDY OF INTRA-ARTERIAL CHEMOTHERAPY WITH OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION FOR PATIENTS WITH RECURRENT OR PROGRESSIVE CNS EMBRYONAL OR GERM CELL TUMORS

Por Das, Paramita, Guillaume, Daniel, Nazemi, Kellie, Moertel, Christopher, Doolittle, Nancy, Lacy, Cynthia, Neuwelt, Edward
Publicado em 2014

“...-brain barrier disruption (BBBD) may improve outcomes in patients with these challenging tumors. METHODS...”
Obter o texto integral
Obter o texto integral

Artigo

16

Palliative Resection of Metastatic Brain Tumors Previously Treated by Stereotactic Radiosurgery

Palliative Resection of Metastatic Brain Tumors Previously Treated by Stereotactic Radiosurgery

Por Jeon, Yoo Sung, Koh, Young-Cho, Song, Sang Woo, Cho, Joon, Lim, So Dug
Publicado no Brain Tumor Res Treat (2016)

“... of preoperative SRS. METHODS: From 2009 to 2015, 174 patients were treated by SRS for brain metastases, and among...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo3

The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo3

Por Tsai, Nu-Man, Chen, Yi-Lin, Lee, Chau-Chin, Lin, Po-Chen, Cheng, Yeung-Leung, Chang, Wen-Liang, Lin, Shinn-Zong, Harn, Horng-Jyh
Publicado em 2006

“...) brain tumors both in vitro and in vivo. In vitro, GBM cells were treated with BP, and the effects...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

RTHP-26. ANALYSIS OF OUTCOMES FROM RE-IRRADIATION WITH PULSED REDUCED DOSE RATE RADIATION THERAPY FOR HIGH GRADE GLIOMAS

RTHP-26. ANALYSIS OF OUTCOMES FROM RE-IRRADIATION WITH PULSED REDUCED DOSE RATE RADIATION THERAPY FOR HIGH GRADE GLIOMAS

Por Burr, Adam, Robins, H, Howard, Steven
Publicado no Neuro Oncol (2018)

“... lower grade gliomas. Treatment was with at an apparent dose rate was 6.67 cGy/min. Median re-irradiation...”
Obter o texto integral
Obter o texto integral

Artigo

19

Craniospinal irradiation using helical tomotherapy for central nervous system tumors

Craniospinal irradiation using helical tomotherapy for central nervous system tumors

Por Schiopu, Sanziana R.I., Habl, Gregor, Häfner, Matthias, Katayama, Sonja, Herfarth, Klaus, Debus, Juergen, Sterzing, Florian
Publicado no J Radiat Res (2017)

“... patients with primary brain tumors treated with helical tomotherapy craniospinal irradiation (HT-CSI). From...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

SURG-20. LASER-INTERSTITIAL THERMAL THERAPY VERSUS CRANIOTOMY FOR TREATMENT OF RADIATION NECROSIS OR RECURRENT TUMOR IN BRAIN METASTASES FAILING RADIOSURGERY

SURG-20. LASER-INTERSTITIAL THERMAL THERAPY VERSUS CRANIOTOMY FOR TREATMENT OF RADIATION NECROSIS OR RECURRENT TUMOR IN BRAIN METASTASES FAILING RADIOSURGERY

Por Hong, Christopher, Deng, Judy, Vera, Alberto, Chiang, Veronica
Publicado no Neuro Oncol (2018)

“... for treatment of radiation necrosis (RN) and re-growing tumor (RT) occurring after radiosurgery for brain...”
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
5
6
7
8
9
10
11
Seguinte
[29]